ACTIQ

1600 Microgram Lozenges

Teva Pharma B.V.PA0749/195/006

Main Information

Trade NameACTIQ
Active SubstancesFENTANYL CITRATE
Strength1600 Microgram
Dosage FormLozenges
Licence HolderTeva Pharma B.V.
Licence NumberPA0749/195/006

Group Information

ATC CodeN02AB03 Phenylpiperidine derivatives

Status

Authorised/WithdrawnAuthorised
Licence Issued09/11/2012
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing StatusNot Marketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceThis product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Educational Materials - HCP

HPRA approval pending

Educational Materials - Patient

HPRA pending approval
« Back

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.